Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $408,300.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHCGet Free Report) President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $13.61, for a total value of $408,300.00. Following the sale, the president now directly owns 1,606,097 shares of the company’s stock, valued at approximately $21,858,980.17. This trade represents a 1.83 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

  • On Friday, November 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $11.35, for a total value of $340,500.00.

Alignment Healthcare Trading Up 0.2 %

Shares of ALHC opened at $14.58 on Monday. Alignment Healthcare, Inc. has a 1-year low of $4.46 and a 1-year high of $14.79. The firm has a market capitalization of $2.79 billion, a price-to-earnings ratio of -18.94 and a beta of 1.45. The firm’s 50-day moving average price is $11.94 and its 200-day moving average price is $10.80. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82.

Alignment Healthcare (NASDAQ:ALHCGet Free Report) last posted its earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.14). The firm had revenue of $692.43 million for the quarter, compared to the consensus estimate of $662.11 million. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The business’s revenue for the quarter was up 51.6% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.19) EPS. Sell-side analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Hedge Funds Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in ALHC. Rhumbline Advisers increased its stake in shares of Alignment Healthcare by 13.3% in the 2nd quarter. Rhumbline Advisers now owns 137,296 shares of the company’s stock worth $1,074,000 after acquiring an additional 16,083 shares in the last quarter. Renaissance Technologies LLC increased its stake in shares of Alignment Healthcare by 16.8% during the second quarter. Renaissance Technologies LLC now owns 1,565,800 shares of the company’s stock valued at $12,245,000 after purchasing an additional 225,000 shares in the last quarter. Hood River Capital Management LLC lifted its holdings in shares of Alignment Healthcare by 6.4% during the second quarter. Hood River Capital Management LLC now owns 3,106,690 shares of the company’s stock valued at $24,294,000 after purchasing an additional 185,854 shares during the last quarter. AQR Capital Management LLC bought a new stake in shares of Alignment Healthcare in the 2nd quarter worth approximately $1,512,000. Finally, Deerfield Management Company L.P. Series C grew its stake in shares of Alignment Healthcare by 31.8% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company’s stock worth $85,250,000 after buying an additional 2,630,788 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Stifel Nicolaus upped their price target on shares of Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday, January 14th. UBS Group raised their price target on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 30th. Barclays boosted their price objective on Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 30th. Stephens restated an “overweight” rating and issued a $17.00 target price on shares of Alignment Healthcare in a report on Thursday, January 2nd. Finally, KeyCorp began coverage on shares of Alignment Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. One analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $11.88.

View Our Latest Analysis on ALHC

About Alignment Healthcare

(Get Free Report)

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Further Reading

Insider Buying and Selling by Quarter for Alignment Healthcare (NASDAQ:ALHC)

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.